These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 10219983)

  • 1. Characterisation of the fish sst3 receptor, a member of the SRIF1 receptor family: atypical pharmacological features.
    Siehler S; Zupanc GK; Seuwen K; Hoyer D
    Neuropharmacology; 1999 Mar; 38(3):449-62. PubMed ID: 10219983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures.
    Siehler S; Nunn C; Zupanc GK; Hoyer D
    Auton Autacoid Pharmacol; 2005 Jan; 25(1):1-16. PubMed ID: 15659149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [125I][Tyr3]octreotide labels human somatostatin sst2 and sst5 receptors.
    Siehler S; Seuwen K; Hoyer D
    Eur J Pharmacol; 1998 May; 348(2-3):311-20. PubMed ID: 9652348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of human recombinant somatostatin receptors. 4. Modulation of phospholipase C activity.
    Siehler S; Hoyer D
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Nov; 360(5):522-32. PubMed ID: 10598791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterisation of human recombinant somatostatin receptors. 1. Radioligand binding studies.
    Siehler S; Seuwen K; Hoyer D
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Nov; 360(5):488-99. PubMed ID: 10598788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of human recombinant somatostatin receptors. 2. Modulation of GTPgammaS binding.
    Siehler S; Hoyer D
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Nov; 360(5):500-9. PubMed ID: 10598789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of human recombinant somatostatin receptors. 3. Modulation of adenylate cyclase activity.
    Siehler S; Hoyer D
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Nov; 360(5):510-21. PubMed ID: 10598790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterisation of human cerebral cortex somatostatin SRIF1 and SRIF2 receptors.
    Piwko C; Thoss VS; Schüpbach E; Kummer J; Langenegger D; Probst A; Hoyer D
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb; 355(2):161-7. PubMed ID: 9050007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterisation of the goldfish somatostatin sst5 receptor.
    Nunn C; Feuerbach D; Lin X; Peter R; Hoyer D
    Eur J Pharmacol; 2002 Feb; 436(3):173-86. PubMed ID: 11858797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution and characterisation of somatostatin receptor mRNA and binding sites in the brain and periphery.
    Fehlmann D; Langenegger D; Schuepbach E; Siehler S; Feuerbach D; Hoyer D
    J Physiol Paris; 2000; 94(3-4):265-81. PubMed ID: 11088004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [125I]Tyr10-cortistatin14 labels all five somatostatin receptors.
    Siehler S; Seuwen K; Hoyer D
    Naunyn Schmiedebergs Arch Pharmacol; 1998 May; 357(5):483-9. PubMed ID: 9650799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloning, expression and pharmacological characterisation of the mouse somatostatin sst(5) receptor.
    Feuerbach D; Fehlmann D; Nunn C; Siehler S; Langenegger D; Bouhelal R; Seuwen K; Hoyer D
    Neuropharmacology; 2000 Jun; 39(8):1451-62. PubMed ID: 10818261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin receptors in the rhesus monkey brain: localization and pharmacological characterization.
    Thoss VS; Piwko C; Hoyer D
    Naunyn Schmiedebergs Arch Pharmacol; 1996 May; 353(6):648-60. PubMed ID: 8738298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoradiographic analysis of somatostatin SRIF1 and SRIF2 receptors in the human brain and pituitary.
    Thoss VS; Piwko C; Probst A; Hoyer D
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb; 355(2):168-76. PubMed ID: 9050008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug design at peptide receptors: somatostatin receptor ligands.
    Hannon JP; Nunn C; Stolz B; Bruns C; Weckbecker G; Lewis I; Troxler T; Hurth K; Hoyer D
    J Mol Neurosci; 2002; 18(1-2):15-27. PubMed ID: 11931345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization and pharmacological characterization of somatostatin recognition sites in the human cerebellum.
    Piwko C; Thoss VS; Probst A; Hoyer D
    Neuropharmacology; 1996 Jun; 35(6):713-23. PubMed ID: 8887980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological identity between somatostatin SS-2 binding sites and SSTR-1 receptors.
    Hoyer D; Pérez J; Schoeffter P; Langenegger D; Schüpbach E; Kaupmann K; Lübbert H; Bruns C; Reubi JC
    Eur J Pharmacol; 1995 Mar; 289(1):151-61. PubMed ID: 7781706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agonist properties of putative small-molecule somatostatin sst2 receptor-selective antagonists.
    Nunn C; Langenegger D; Hurth K; Schmidt K; Fehlmann D; Hoyer D
    Eur J Pharmacol; 2003 Apr; 465(3):211-8. PubMed ID: 12681432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterisation of native somatostatin receptors in AtT-20 mouse tumour corticotrophs.
    Cervia D; Nunn C; Fehlmann D; Langenegger D; Schuepbach E; Hoyer D
    Br J Pharmacol; 2003 May; 139(1):109-21. PubMed ID: 12746229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and pharmacological characterization of somatostatin receptors in rat lung.
    Schloos J; Raulf F; Hoyer D; Bruns C
    Br J Pharmacol; 1997 Jul; 121(5):963-71. PubMed ID: 9222554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.